Sign up
Log in
MARKET
RVTY
RVTY
Revvity Inc
NYSE
115.15
+2.34
+2.07%
After Hours: 115.15 0 0.00% 16:46 07/26 EDT
OPEN
113.94
PREV CLOSE
112.81
HIGH
116.78
LOW
113.31
VOLUME
1.38M
TURNOVER
0
52 WEEK HIGH
131.96
52 WEEK LOW
79.34
MARKET CAP
14.21B
P/E (TTM)
95.35
1D
5D
1M
3M
1Y
5Y
1D
Martin Zweig Detailed Fundamental Analysis - RVTY
NASDAQ · 5h ago
Pre-Market Earnings Report for July 29, 2024 : MCD, ON, RVTY, CNA, AMG, ARLP, IART, HOPE, BMRC, OIS, CIVB, PROV
NASDAQ · 5h ago
Revvity Q2 2024 Earnings Preview
Revvity, Inc. Is scheduled to announce Q2 earnings results on Monday, July 29th. The consensus EPS Estimate is $1.12 and the consensus revenue estimate is $689.2M. Over the last 2 years, RVTY has beaten EPS estimates 75% of the time.
Seeking Alpha · 8h ago
Revvity (RVTY) to Report Q2 Earnings: What's in the Cards?
NASDAQ · 8h ago
Notable earnings before Monday's open
Major earnings expected before the bell on Monday include: McDonald's, ON Semiconductor, and Loews. Other major earnings slated for release before Monday's open include: AMG, CNA, and AVTR. Notable earnings before the open include Alliance Resource Partners and McDonald's.
Seeking Alpha · 10h ago
Press Release: Revvity Board Declares Quarterly Dividend
Dow Jones · 1d ago
Revvity Board Declares Quarterly Dividend
Revvity declares a regular quarterly dividend of $0.07 per share of common stock. The dividend is payable on November 8, 2024 to all shareholders of record on October 18, 2024. Revvity provides health science solutions, technologies, expertise and services. The company has 2023 revenue of more than $2.7 billion.
Barchart · 1d ago
What You Need to Know Ahead of Revvity’s Earnings Release
Revvity, Inc. (RVTY) is expected to announce its fiscal second-quarter earnings for 2024 before the market opens on Jul. 29. The company provides health sciences solutions, technologies, and services. RVTY stock has underperformed the S&P 500’s 16.7% gains on a YTD basis.
Barchart · 3d ago
About RVTY
Revvity, Inc. is a provider of health science solutions, technologies, and services, which delivers workflows from discovery to development, and diagnosis to cure. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The Life Sciences Segment applications include MicroBeta, The MuviCyte live-cell imaging system, The Signals Image Artist, The VICTOR Nivo multimode plate reader benchtop system, The EnSight multimode plate reader benchtop system, BioLegend LEGENDplex bead-based reagents, and The Quantum GX2 system. Its Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. It offers instruments, reagents, assay platforms and software to hospitals, and medical labs. It is focused on reproductive health, immunodiagnostics, and emerging market diagnostics.
Webull offers Revvity Inc stock information, including NYSE: RVTY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVTY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading RVTY stock methods without spending real money on the virtual paper trading platform.